Over 70% of PCa cases exhibit AR pathway aberrations, including those involving SPOP or FOXA1, with the majority resulting from direct alterations affecting AR through amplifications and mutations [36]. The gene discussed is FOXA1; the disease is posterior cortical atrophy.